Page last updated: 2024-11-08

triiodothyronine and Amyotrophic Lateral Sclerosis

triiodothyronine has been researched along with Amyotrophic Lateral Sclerosis in 9 studies

Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research Excerpts

ExcerptRelevanceReference
"Thyronine (T4), triiodothyronine (T3), and reverse-triiodothyronine (rT3) levels were evaluated in cerebrospinal fluid (CSF) and in serum of 12 patients with definite amyotrophic lateral sclerosis (ALS) by specific radioimmunoassays."3.67T4, T3 and rT3 levels in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. ( Fuhrmann, H; Ködding, R; Malin, JP; von zur Mühlen, A, 1989)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19903 (33.33)18.7374
1990's4 (44.44)18.2507
2000's1 (11.11)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zheng, Z1
Guo, X1
Huang, R1
Chen, X1
Shang, H1
Iłzecka, J1
Stelmasiak, Z1
Nobukuni, K1
Hayakawa, N1
Namba, R1
Ihara, Y1
Sato, K1
Takada, H1
Hayabara, T1
Kawahara, S1
Golovkin, VI1
Korovin, KF1
Iampol'skaia, LI1
Dobrov, SA1
Chiodini, PG2
Attanasio, R2
Liuzzi, A1
Cozzi, R1
Orlandi, P1
De Palo, C1
Dallabonzana, D1
Girotti, F2
Testa, D2
Malin, JP1
Ködding, R1
Fuhrmann, H1
von zur Mühlen, A1
Kaplan, MM1
Taft, JA1
Reichlin, S1
Munsat, TL1
Gueguen, B1
Puymirat, J1
Grouselle, D1
Piketty, ML1
Bleton, JP1
Bourdel, MC1
Rondot, P1

Other Studies

9 other studies available for triiodothyronine and Amyotrophic Lateral Sclerosis

ArticleYear
An exploratory study of the association between thyroid hormone and survival of amyotrophic lateral sclerosis.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014, Volume: 35, Issue:7

    Topics: Adult; Age of Onset; Aged; Amyotrophic Lateral Sclerosis; China; Female; Humans; Male; Middle Aged;

2014
Thyroid function in patients with amyotrophic lateral sclerosis.
    Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 2003, Volume: 58, Issue:1

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Case-Control Studies; Female; Humans; Male; Middle Aged;

2003
The influence of long-term treatment with povidone-iodine on thyroid function.
    Dermatology (Basel, Switzerland), 1997, Volume: 195 Suppl 2

    Topics: Amyotrophic Lateral Sclerosis; Anti-Infective Agents, Local; Catheterization, Central Venous; Female

1997
[Neuroendocrine aspects of the pathogenesis and treatment of disseminated sclerosis and lateral amyotrophic sclerosis].
    Sovetskaia meditsina, 1990, Issue:5

    Topics: Adult; Amyotrophic Lateral Sclerosis; Arginine Vasopressin; Diagnosis, Differential; Drug Therapy, C

1990
Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.
    Journal of endocrinological investigation, 1990, Volume: 13, Issue:8

    Topics: Amyotrophic Lateral Sclerosis; Down-Regulation; Female; Growth Hormone; Growth Hormone-Releasing Hor

1990
Amyotrophic lateral sclerosis: thyroid and prolactin hormone changes in thyrotropin-releasing hormone therapy.
    Italian journal of neurological sciences, 1990, Volume: 11, Issue:6

    Topics: Amyotrophic Lateral Sclerosis; Female; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged;

1990
T4, T3 and rT3 levels in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Journal of neurology, 1989, Volume: 236, Issue:1

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Female; Humans; Male; Middle Aged; Thyronines; Triiodoth

1989
Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 63, Issue:4

    Topics: Amyotrophic Lateral Sclerosis; Female; Humans; Long-Term Care; Male; Pituitary Function Tests; Prola

1986
[Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
    Revue neurologique, 1988, Volume: 144, Issue:11

    Topics: Acetylcholinesterase; Adult; Aged; Amyotrophic Lateral Sclerosis; Female; Follicle Stimulating Hormo

1988